Study of Cold-Therapy Device to Reduce Pain After Double Lung Transplant Surgery

What this Trial Is About

This research aims to evaluate a new method to manage pain after a double lung transplant. It focuses on whether using a cold-therapy probe during surgery can reduce the need for opioid pain medicines and improve recovery. The study compares patients receiving this cold treatment to those receiving usual care to understand its impact on pain control and opioid use. During surgery, some patients will receive treatment with the Atricure CryoSPHERE MAX Probe, which gently freezes nerves around the incision to numb pain for several days. This device is applied to two intercostal spaces above and below the thoracotomy incision for one minute each time during the transplant procedure. Other patients will receive the standard care without this device. The study follows participants for one year after their transplant to assess long-term effects. Participants will be closely monitored through the first 10 days after surgery for opioid use, pain scores, need for additional pain treatments, and time spent in the intensive care unit. Researchers will measure total opioid use over one year and track recovery progress. Safety and recovery will be observed with ongoing follow-up visits throughout the year to understand how well this cold-therapy method helps patients after lung transplant surgery.

Intercostal Cryoanalgesia in Double Lung Transplant Recipients